Tag: NASDAQ:NTLA

Finance

Intellia Therapeutics Inc (NTLA): A New Perspective

Intellia Therapeutics Inc (NASDAQ:NTLA) concluded the trading at $9.22 on Thursday, March 13 with a fall of -4.16% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.62 and 5Y monthly beta

Companies

Why Has Intellia Therapeutics Inc (NASDAQ: NTLA) Declined So Much?

Intellia Therapeutics Inc (NASDAQ:NTLA) traded at $9.46 at close of the session on Monday, March 10 and made a downward move of -8.60% on its previous day’s price. Intellia Therapeutics Inc has a market cap of $979.28 million and is expected to release its quarterly